| pubmed-article:8196571 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8196571 | lifeskim:mentions | umls-concept:C0021311 | lld:lifeskim |
| pubmed-article:8196571 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:8196571 | lifeskim:mentions | umls-concept:C1257890 | lld:lifeskim |
| pubmed-article:8196571 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:8196571 | lifeskim:mentions | umls-concept:C0200627 | lld:lifeskim |
| pubmed-article:8196571 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:8196571 | lifeskim:mentions | umls-concept:C1136254 | lld:lifeskim |
| pubmed-article:8196571 | lifeskim:mentions | umls-concept:C1096776 | lld:lifeskim |
| pubmed-article:8196571 | lifeskim:mentions | umls-concept:C1880496 | lld:lifeskim |
| pubmed-article:8196571 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:8196571 | pubmed:dateCreated | 1994-6-27 | lld:pubmed |
| pubmed-article:8196571 | pubmed:abstractText | Severe infections are the predominant cause of treatment failure in patients with high grade malignant hematological disorders undergoing intensive chemotherapy. | lld:pubmed |
| pubmed-article:8196571 | pubmed:language | ger | lld:pubmed |
| pubmed-article:8196571 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8196571 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8196571 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8196571 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8196571 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:8196571 | pubmed:issn | 0723-5003 | lld:pubmed |
| pubmed-article:8196571 | pubmed:author | pubmed-author:MeyerPP | lld:pubmed |
| pubmed-article:8196571 | pubmed:author | pubmed-author:LindAA | lld:pubmed |
| pubmed-article:8196571 | pubmed:author | pubmed-author:SchmittJJ | lld:pubmed |
| pubmed-article:8196571 | pubmed:author | pubmed-author:AdamDD | lld:pubmed |
| pubmed-article:8196571 | pubmed:author | pubmed-author:HiddemannWW | lld:pubmed |
| pubmed-article:8196571 | pubmed:author | pubmed-author:MaschmeyerGG | lld:pubmed |
| pubmed-article:8196571 | pubmed:author | pubmed-author:EisenmannEE | lld:pubmed |
| pubmed-article:8196571 | pubmed:author | pubmed-author:HelmerkingMM | lld:pubmed |
| pubmed-article:8196571 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8196571 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:8196571 | pubmed:volume | 89 | lld:pubmed |
| pubmed-article:8196571 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8196571 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8196571 | pubmed:pagination | 114-23 | lld:pubmed |
| pubmed-article:8196571 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:8196571 | pubmed:meshHeading | pubmed-meshheading:8196571-... | lld:pubmed |
| pubmed-article:8196571 | pubmed:meshHeading | pubmed-meshheading:8196571-... | lld:pubmed |
| pubmed-article:8196571 | pubmed:meshHeading | pubmed-meshheading:8196571-... | lld:pubmed |
| pubmed-article:8196571 | pubmed:meshHeading | pubmed-meshheading:8196571-... | lld:pubmed |
| pubmed-article:8196571 | pubmed:meshHeading | pubmed-meshheading:8196571-... | lld:pubmed |
| pubmed-article:8196571 | pubmed:meshHeading | pubmed-meshheading:8196571-... | lld:pubmed |
| pubmed-article:8196571 | pubmed:meshHeading | pubmed-meshheading:8196571-... | lld:pubmed |
| pubmed-article:8196571 | pubmed:meshHeading | pubmed-meshheading:8196571-... | lld:pubmed |
| pubmed-article:8196571 | pubmed:meshHeading | pubmed-meshheading:8196571-... | lld:pubmed |
| pubmed-article:8196571 | pubmed:meshHeading | pubmed-meshheading:8196571-... | lld:pubmed |
| pubmed-article:8196571 | pubmed:meshHeading | pubmed-meshheading:8196571-... | lld:pubmed |
| pubmed-article:8196571 | pubmed:meshHeading | pubmed-meshheading:8196571-... | lld:pubmed |
| pubmed-article:8196571 | pubmed:meshHeading | pubmed-meshheading:8196571-... | lld:pubmed |
| pubmed-article:8196571 | pubmed:meshHeading | pubmed-meshheading:8196571-... | lld:pubmed |
| pubmed-article:8196571 | pubmed:meshHeading | pubmed-meshheading:8196571-... | lld:pubmed |
| pubmed-article:8196571 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:8196571 | pubmed:articleTitle | [Empirical antimicrobial therapy in neutropenic patients. Results of a multicenter study by the Infections in Hematology Study Group of the Paul Ehrlich Society]. | lld:pubmed |
| pubmed-article:8196571 | pubmed:affiliation | Universitätsklinikum Rudolf Virchow, Robert-Rössle-Klinik, Abt. Med. Onkologie und Angewandte Molekularbiologie, Berlin. | lld:pubmed |
| pubmed-article:8196571 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8196571 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:8196571 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:8196571 | pubmed:publicationType | English Abstract | lld:pubmed |
| pubmed-article:8196571 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:8196571 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8196571 | lld:pubmed |
